Literature DB >> 1370970

The role of dextran 40 and potassium in extended hypothermic lung preservation for transplantation.

S H Keshavjee1, F Yamazaki, H Yokomise, P F Cardoso, J B Mullen, A S Slutsky, G A Patterson.   

Abstract

We have previously demonstrated that a low-potassium dextran solution provides superior and more reliable preservation of lungs for 12 hours than that provided by the commonly used Euro-Collins solution. This study was designed to examine the individual contributions of dextran 40 and a low (extracellular) potassium concentration to lung preservation. In a randomized, blinded study using an in vivo canine single-lung transplant model, lungs preserved with low-potassium dextran solution (K+, 4 mmol/L; dextran 40, 20 gm/L) were compared to lungs preserved with low-potassium, no-dextran solution (K+, 4 mmol/L) and high-potassium dextran solution (K+, 123 mmol/L; dextran 40, 20 gm/L). The lungs were assessed immediately and 3 days after transplantation. The low-potassium dextran solution provided excellent immediate pulmonary function with little variability (arterial oxygen tension, 519 +/- 12 mm Hg, measured on the transplanted lung alone, inspired oxygen fraction = 1.0, n = 6). Removing the dextran 40 from the flush solution (low-potassium group) led to a significant deterioration in pulmonary function (arterial oxygen tension, 243 +/- 78 mm Hg, n = 6, p less than 0.01). The high-potassium dextran solution provided extremely poor preservation (arterial oxygen tension, 176 +/- 79 mm Hg; n = 6; p less than 0.01). Two animals in this group died within 6 hours of operation. Viability of the transplanted bronchus was significantly improved with the two solutions containing dextran 40. These results indicate that dextran 40 and low potassium concentration both contribute significantly to the uniformly excellent 12-hour lung preservation seen with the low-potassium dextran solution.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370970

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  10 in total

1.  Clinical application of an extracellular phosphate-buffered solution (EP-TU) for lung preservation: preliminary results of a Japanese series.

Authors:  Yoshinori Okada; Yuji Matsumura; Hiroshi Date; Toru Bando; Takahiro Oto; Tetsu Sado; Yasushi Hoshikawa; Masafumi Noda; Hisashi Oishi; Takashi Kondo
Journal:  Surg Today       Date:  2011-11-18       Impact factor: 2.549

Review 2.  Preservation solution for lung transplantation.

Authors:  Yoshinori Okada; Takashi Kondo
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-12

Review 3.  Overview of clinical lung transplantation.

Authors:  Jonathan C Yeung; Shaf Keshavjee
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

4.  Cell death in human lung transplantation: apoptosis induction in human lungs during ischemia and after transplantation.

Authors:  S Fischer; S D Cassivi; A M Xavier; J A Cardella; E Cutz; V Edwards; M Liu; S Keshavjee
Journal:  Ann Surg       Date:  2000-03       Impact factor: 12.969

5.  Ultrastructural damage to the preserved lung and its function after reperfusion.

Authors:  Shinji Kosaka; Mitsuhiro Ueda; Toru Bando; Chun Jiang Liu; Shigeki Hitomi; Hiromi Wada
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-01

6.  National Heart, Lung, and Blood Institute and American Association for Thoracic Surgery Workshop Report: Identifying collaborative clinical research priorities in lung transplantation.

Authors:  Michael S Mulligan; David Weill; R Duane Davis; Jason D Christie; Farhood Farjah; Jonathan P Singer; Matthew Hartwig; Pablo G Sanchez; Daniel Kreisel; Lorraine B Ware; Christian Bermudez; Ramsey R Hachem; Michael J Weyant; Cynthia Gries; Jeremiah W Awori Hayanga; Bartley P Griffith; Laurie D Snyder; Jonah Odim; J Matthew Craig; Neil R Aggarwal; Lora A Reineck
Journal:  J Thorac Cardiovasc Surg       Date:  2018-08-18       Impact factor: 5.209

7.  Evaluation of Early Markers of Ischemia-reperfusion Injury and Preservation Solutions in a Modified Hindlimb Model of Vascularized Composite Allotransplantation.

Authors:  Sara Rostami; Michael Xu; Shaishav Datta; Siba Haykal
Journal:  Transplant Direct       Date:  2021-12-13

Review 8.  Airway complications in lung transplantation.

Authors:  Maria M Crespo
Journal:  J Thorac Dis       Date:  2021-11       Impact factor: 2.895

9.  Donor lung preservation for transplantation-where do we go from here?

Authors:  Dirk Van Raemdonck; Jan Van Slambrouck; Laurens J Ceulemans
Journal:  J Thorac Dis       Date:  2022-09       Impact factor: 3.005

10.  The impact of topically applied preservation solutions on the respiratory epithelium of tracheal grafts submitted to cold ischemia: functional and morphological analysis.

Authors:  Artur Eugênio de Azevedo-Pereira; Juliana Akemi Saka; Karina Andrighetti de Oliveira-Braga; Rogério Pazetti; Mauro Canzian; Paulo Manuel Pêgo-Fernandes; Fabio Biscegli Jatene
Journal:  Clinics (Sao Paulo)       Date:  2013-05       Impact factor: 2.365

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.